{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:42:38Z","timestamp":1790023358565,"version":"4.0.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Hepatoid carcinoma of the ovary (HCO) is a highly uncommon and aggressive neoplasm originating from the surface epithelial cells of the ovary, characterized by hepatocyte-like differentiation. To date, most information on HCO is derived from case reports, with fewer than 50 documented cases globally. In this case report, we present a detailed account of the diagnosis, treatment, and prognosis of a patient diagnosed as having bilateral HCO, which is even rarer. Targeted next-generation sequencing revealed somatic mutations in PIK3C3 and TP53, with no BRCA1\/2 alterations, and a molecular profile consistent with microsatellite stability and low tumor mutational burden. We also review the current literature to situate our findings within the broader context of existing knowledge. Given the rarity of bilateral HCO, our objective is to contribute to the existing body of knowledge by providing a comprehensive description of its clinical features, molecular characteristics, and treatment strategies. This effort may enhance understanding of this rare malignancy and offer insights to improve patient outcomes in clinical practice.<\/jats:p>","DOI":"10.3389\/fonc.2025.1631424","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T11:27:14Z","timestamp":1755862034000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: A rare case of hepatoid carcinoma of the ovary with genomic profiling and long-term follow-up: diagnostic and therapeutic perspectives"],"prefix":"10.3389","volume":"15","author":[{"given":"Yufang","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangsheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihai","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengnong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19871201)60:11<2775::AID-CNCR2820601130>3.0.CO;2-S","article-title":"Hepatoid carcinoma of the ovary. A newly described tumor","volume":"60","author":"Ishikura","year":"1987","journal-title":"Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e7706","DOI":"10.1002\/ccr3.7706","article-title":"SALL4 as an indicator for the diagnosis of hepatoid carcinoma of the ovary: A case report and literature review","volume":"11","author":"Li","year":"2023","journal-title":"Clin Case Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e20051","DOI":"10.1097\/MD.0000000000020051","article-title":"Primary hepatoid carcinoma of the ovary: A\u00a0case report and review of the literature","volume":"99","author":"Choi","year":"2020","journal-title":"Med (Baltimore)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2017-0485-RS","article-title":"Hepatoid carcinoma of the ovary: clinical, histopathologic, and immunophenotypic features","volume":"143","author":"Acosta","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-199107000-00009","article-title":"Hepatoid carcinoma of the ovary: a case report","volume":"10","author":"Matsuta","year":"1991","journal-title":"Int J Gynecol Pathol"},{"key":"B6","article-title":"Ovarian tumor with hepatoid differentiation. Discussion and review of the literature. Report of a case","volume":"13","author":"Badreddine","year":"1993","journal-title":"Ann Pathol"},{"key":"B7","article-title":"A case report of hepatoid carcinoma of the ovary","volume":"45","author":"Tamakoshi","year":"1993","journal-title":"Nihon Sanka Fujinka Gakkai Zasshi"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1438.1995.05040314.x","article-title":"Ovarian hepatoid carcinoma without staining for alpha-fetoprotein in the primary site","volume":"5","author":"Nishida","year":"1995","journal-title":"Int J Gynecol Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1996.0293","article-title":"Combined ovarian serous papillary and hepatoid carcinoma","volume":"63","author":"Scurry","year":"1996","journal-title":"Gynecol Oncol"},{"key":"B10","article-title":"Hepatoid carcinoma of the ovary\u2013a case report","volume":"19","author":"Trivedi","year":"1998","journal-title":"Eur J Gynaecol Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(98)70092-4","article-title":"Primary hepatoid carcinoma of ovary in pregnancy","volume":"179","author":"Maymon","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.1999.00840.x","article-title":"An autopsy case of hepatoid carcinoma of the ovary with PIVKA-II production: immunohistochemical study and literature review","volume":"49","author":"Senzaki","year":"1999","journal-title":"Pathol Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2002.811115.x","article-title":"A hepatoid carcinoma of the ovary","volume":"81","author":"Lee","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000326479","article-title":"Cytopathologic and clinicopathologic features of ovarian hepatoid carcinoma","volume":"47","author":"Watanabe","year":"2003","journal-title":"A Case Rep Acta Cytol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/01.PGP.0000055173.04957.66","article-title":"Hepatoid carcinoma of the ovary: a report of three cases admixed with a common surface epithelial carcinoma","volume":"22","author":"Tochigi","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"B16","article-title":"Hepatoid carcinoma of the ovary: characteristics of its immunoreactivity","volume":"25","author":"Tsung","year":"2004","journal-title":"A Case Rep Eur J Gynaecol Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-00009577-200605000-00075","article-title":"Hepatoid carcinoma of the ovary: immunohistochemical finding of one case and literature review","volume":"16","author":"Yi\u011fit","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-00009577-200607000-00032","article-title":"No ancillary finding is valid to distinguish a primary ovarian hepatoid carcinoma from metastatic hepatocellular carcinoma","volume":"16","author":"Kwon","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/00016340600593117","article-title":"Hepatoid carcinoma of the ovary and management","volume":"86","author":"Lazaro","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B20","article-title":"A case of hepatoid carcinoma of the ovary","volume":"29","author":"Ozan","year":"2008","journal-title":"Eur J Gynaecol Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1159\/000325560","article-title":"Cytologic features of hepatoid carcinoma of the ovary: a case report with immunocytologic evaluation of HepPar1","volume":"52","author":"Tejerina Gonz\u00e1lez","year":"2008","journal-title":"Acta Cytol"},{"key":"B22","article-title":"Hepatoid carcinoma of the ovary","volume":"30","author":"Zizi-Sermpetzoglou","year":"2009","journal-title":"A Case Rep Rev Literat Eur J Gynaecol Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-008-0800-4","article-title":"Alpha-fetoprotein (AFP)-producing ovarian tumor in an elderly woman","volume":"14","author":"Isonishi","year":"2009","journal-title":"Int J Clin Oncol"},{"key":"B24","article-title":"Hepatoid carcinoma of ovary: A case report","volume":"43","author":"Sun","year":"2009"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-009-1259-x","article-title":"Hepatoid carcinoma of the ovary with sex cord stromal tumor: a previously unrecognized association","volume":"281","author":"D\u2019Antonio","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.6321","article-title":"Hepatoid carcinoma of the ovary","volume":"29","author":"Pandey","year":"2011","journal-title":"J Clin Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2012.879","article-title":"Hepatoid carcinoma of the ovary: A case report and review of the literature","volume":"4","author":"Liu","year":"2012","journal-title":"Oncol Lett"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.5468\/OGS.2013.56.1.41","article-title":"Hepatoid carcinoma of the ovary without staining for alpha-fetoprotein","volume":"56","author":"Sung","year":"2013","journal-title":"Obstet Gynecol Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"283295","DOI":"10.1155\/2013\/283295","article-title":"Peritoneal dissemination of hepatoid carcinoma of the ovary treated with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy","volume":"2013","author":"Cascales","year":"2013","journal-title":"Case Rep Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1477-7819-11-29","article-title":"Clinical and pathological features of hepatoid carcinoma of the ovary","volume":"11","author":"Wang","year":"2013","journal-title":"World J Surg Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.5455\/2320-1770.ijrcog20140952","article-title":"Hepatoid carcinoma of ovary: a very rare histopathological finding","volume":"3","author":"Wani","year":"2014","journal-title":"Int J Reprod Contracep Obstetr Gynecol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.11604\/pamj.2015.20.93.5953","article-title":"Primary hepatoid carcinoma of the ovary: a case report","volume":"20","author":"Mazouz","year":"2015","journal-title":"Pan Afr Med J"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2015.06.006","article-title":"Hepatoid carcinoma of the ovary: A case report and review of the literature","volume":"13","author":"Randolph","year":"2015","journal-title":"Gynecol Oncol Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5851.195744","article-title":"A rare case of hepatoid carcinoma of the ovary with pancytopenia and hypocellular marrow","volume":"37","author":"Lakhotia","year":"2016","journal-title":"Indian J Med Paediatr Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2016.08.020","article-title":"A case report of Hepatoid Carcinoma of the Ovary with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy without systemic adjuvant therapy","volume":"27","author":"Naffouje","year":"2016","journal-title":"Int J Surg Case Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2017.05.007","article-title":"Metastatic hepatoid carcinoma of ovarian origin - a case report from northern Pakistan","volume":"21","author":"Mahmood","year":"2017","journal-title":"Gynecol Oncol Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40944-020-0371-5","article-title":"A rare case of hepatoid carcinoma of the ovary with mini review of literature","volume":"18","author":"Ghosh","year":"2020","journal-title":"Indian J Gynecol Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"100564","DOI":"10.1016\/j.gore.2020.100564","article-title":"Hepatoid carcinoma of the ovary - A case report and literature review","volume":"32","author":"Uribe","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S288913","article-title":"Extra-hepatic hepatoid carcinomas in female reproductive system: three case-reports with a literature review","volume":"13","author":"Liu","year":"2021","journal-title":"Cancer Manag Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1177\/10668969241260811","article-title":"Whole-exome sequencing identifies germline BLM mutation in ovarian hepatoid adenocarcinoma with favorable response to niraparib and anlotinib combination therapy-A case report and literature review","volume":"33","author":"Zhang","year":"2024","journal-title":"Int J Surg Pathol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2023.24.2.693","article-title":"Endometrial thickness measurement as predictor of endometrial hyperplasia and cancer in perimenopausal uterine bleeding: cross-sectional study","volume":"24","author":"Thoprasert","year":"2023","journal-title":"Asian Pac J Cancer Prev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/dc.23920","article-title":"Metastatic hepatocellular carcinoma diagnosed by fine needle aspiration: A clinical and cytologic study","volume":"46","author":"Yan","year":"2018","journal-title":"Diagn Cytopathol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/13651820410024049","article-title":"Diagnosis of hepatocellular carcinoma","volume":"7","author":"Bialecki","year":"2005","journal-title":"HPB (Oxford)"},{"key":"B44","volume-title":"Clear cell carcinoma of the ovary, in pathology of the ovary, fallopian tube and peritoneum","author":"Chapel","year":"2023"},{"key":"B45","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1080\/17843286.2021.1964051","article-title":"A clearer view on ovarian clear cell carcinoma","volume":"77","author":"De Pauw","year":"2022","journal-title":"Acta Clin Belg"},{"key":"B46","doi-asserted-by":"publisher","first-page":"113107","DOI":"10.1016\/j.intimp.2024.113107","article-title":"MCM4 potentiates evasion of\u00a0hepatocellular carcinoma from sorafenib-induced ferroptosis through Nrf2 signaling pathway","volume":"142","author":"Liu","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000541018","article-title":"Lenvatinib versus sorafenib second-line therapy in patients with hepatocellular carcinoma progressed to atezolizumab plus bevacizumab: a retrospective real-world study","author":"Persano","year":"2024","journal-title":"Oncology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-16-0003","article-title":"Understanding TERT promoter mutations: A common path to immortality","volume":"14","author":"Bell","year":"2016","journal-title":"Mol Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.molcel.2017.07.003","article-title":"Vps34 kinase domain dynamics regulate the autophagic PI 3-kinase complex","volume":"67","author":"Stjepanovic","year":"2017","journal-title":"Mol Cell"},{"key":"B50","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41419-020-2631-9","article-title":"PIK3C3 regulates the expansion of liver CSCs and PIK3C3 inhibition counteracts liver cancer stem cell activity induced by PI3K inhibitor","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1631424\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T11:27:18Z","timestamp":1755862038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1631424\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":50,"alternative-id":["10.3389\/fonc.2025.1631424"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1631424","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"article-number":"1631424"}}